Delivery Order SPE2DB22D3301-SPE2DB24FY1LE
- Not listed
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the for-profit parent company Cencora, Inc. doing business as Amerisourcebergen. The contract provides for the delivery of 4,563,774,599 milliliters of a 250 milligram per 5 milliliter solution of valproic acid, a pharmaceutical drug, with a potential value of $4,781.05. The contract has a completion date of February 27, 2024 and was awarded on February 26, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,184.71, is for the delivery of DIVALPROEX SOD ER 500 MG TAB 500S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 4, 2024. The award is not associated with a set-aside designation, indicating open...
- This federal contract award is for the delivery of valacyclovir hydrochloride, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $1,082.33 and a completion date of October 25, 2023. It does not have a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $1,377.46, is for the procurement of Procainamide 1 gram/10 ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
- This federal contract award is for the delivery of Valacyclovir HCL 500 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $10,056.42 firm fixed-price contract was awarded on May 23, 2022 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 24, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,483.58, is a delivery order for the supply of 4566554566 ACETAMINOPHEN 1,000MG/100ML VL 100ML. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at up to $1,066.26, is for the delivery of Divalproex Sodium Extended-Release 500 mg Tablets. The award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award is for the delivery of Valacyclovir 1GM 90S, a pharmaceutical medication, to the Defense Logistics Agency (DLA). The $13,694.13 firm fixed-price contract with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an ultimate completion date of July 31, 2025. The contract is not set aside and is funded by the DLA, which is the primary logistics combat support agency for the United States Armed Forces. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $22,542.94 and provides for the delivery of Valganciclovir HCL 50 mg/ml 88ml, a pharmaceutical product, through January 23, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $3,331.00, is for the delivery of acetaminophen 1,000mg/100ml vials. This is a firm fixed-price delivery order contract with a completion date of July 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1LEDelivery Order
This federal contract award is for the delivery of Valproic Acid 250 mg/5 ml solution in 473 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $14,100.38, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of February 28, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as AmerisourceBergen. Both companies are registered in the System for Award Management (SAM.gov) as for-profit organizations. The contract award was made through full and open competition, without any set-aside designations. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 2/27/24 |